Angiotensin II receptor antagonists are agents used to modify the renin-angiotensin-aldosterone system (RAAS) through blocking angiotensin receptors. This has the effect of lowering blood pressure.

The renin-angiotensin-aldosterone system (RAAS) is now known to play a key role in the pathogenesis of hypertension and a range of other cardiovascular diseases. Two groups of drugs, the ACE ...

There is increasing evidence of a clinically relevant interplay between the renin–angiotensin–aldosterone system and calcium-regulatory systems. Classically, the former is considered a key regulator ...

Angiotensin receptor blockers are antihypertensive medicines used to treat high blood pressure. They act as vasodilators, widening the blood vessels (vasodilation) and reducing blood pressure. The ...

Given the common use of ACE inhibitors and ARBs worldwide, guidance on the use of these drugs in patients with Covid-19 is urgently needed. Here, we highlight that the data in humans are too limited ...

Recent concerns that common antihypertensive drugs may have a negative effect in COVID-19 patients are not supported by the evidence, report scientists in a new review published in Mayo Clinic ...

Angiotensin II (AT-II)-Receptor Antagonists are Reviewed. Research focused on blocking the renin- angiotensin system (RAS) led to the discovery of angiotensin-converting-enzyme (ACE) inhibitors, which ...